ImStar Therapeutics imstartx.com


Public list: Pharma Startups (4740) Neuroscience Startups (942)

ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. ImStar Therapeutics is developing treatments directed at a proprietary new therapeutic target recently discovered for ALS called TANA or TDP-43 Associated NF-kB Activation.

ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. ImStar Therapeutics is developing treatments directed at a proprietary new therapeutic tar...Show all

Company (Alive / Active)

Phone:

Fax:

1285 West Broadway,
Suite 600
Vancouver, V6H 3X8
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImStar Therapeutics $1.8M Jun 10, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImStar Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Withanolides useful for the treatment of neurodegenerative diseases Nov 25, 2014 Application